Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

Combining conventional and integrative treatments can help reduce hair loss and improve hair growth in women with androgenic alopecia.

This review discusses the emotional impact of androgenetic alopecia and emphasizes the importance of integrating emotional support into dermatological nursing care to improve patient outcomes.

This study highlights the potential of polymeric micelles in enhancing the targeted delivery and efficacy of treatments for androgenetic alopecia, by offering improved retention on the scalp, extended release, and reduced systemic side effects compared to conventional therapies like minoxidil and finasteride.

This study reviewed recent advancements in treating androgenetic alopecia, reporting that while minoxidil and 5-alpha-reductase inhibitors remain well-supported treatments, emerging therapies like microneedling, platelet-rich plasma, low-level laser, and regenerative medicine show promising complementary results.

This review discusses female androgenic alopecia, highlighting its potential difference from male androgenic alopecia and notes increased incidence, but reports no new clinical findings.

This study reports that dermatologists account for only 23% of social media posts about AGA therapy but have the highest average follower count, suggesting they could significantly enhance education on these platforms.

This study evaluated the therapeutic response of an Afro-descendant patient with non-scarring alopecia after prolonged use of alkaline straighteners and mechanical traction, highlighting the susceptibility of Afro hair to chemical and mechanical damage due to its structure.

This study found that patients with androgenetic alopecia and alopecia areata experienced a significant impact on quality of life, with moderate levels of anxiety and depression, and no significant difference in psychiatric comorbidities between the groups.

This study aimed to evaluate the incidence of telogen effluvium in patients from Guanambi-BA who had a prior COVID-19 infection, noting a lack of extensive research on the connection between COVID-19 and the development of this hair loss condition.

In this study, several dermoscopic features such as hair diameter diversity, brown peripilar sign, and focal atrichia were frequently observed in both male and female androgenetic alopecia patients, highlighting these as potential AGA indicators.

In a cross-sectional study, 46% of patients with androgenetic alopecia were found to have depression of borderline to moderate severity, while 62% reported no impact on their quality of life, emphasizing the need for awareness of psychiatric comorbidities among dermatologists.

This literature review found that androgenetic alopecia has a complex multifactorial etiology and effective management should be tailored to individual severity and gender to improve patients' quality of life.

This article reviews nonscarring and scarring hair loss conditions that may mimic androgenetic alopecia, reporting no new clinical results and highlighting the need for accurate diagnosis in hair restoration surgery.

This study found that androgenetic alopecia is significantly associated with moderate impairment of health-related quality of life and emotions, but not with depressive symptoms.

This article is a letter to the editor about attempts to target microinflammation in androgenetic alopecia and includes no new clinical results.

This article reviews temporal triangular alopecia, emphasizing the utility of dermoscopy for diagnosis, and reports no new clinical treatment findings.

In this case report, a 74-year-old woman with progressive alopecia unresponsive to minoxidil was diagnosed with Graham-Little-Piccardi-Lassueur Syndrome, illustrating the value of interdisciplinary collaboration in primary care for accurate diagnosis and improved patient outcomes.

In this study, reflectance confocal microscopy was shown to provide early insights into sub-clinical treatment progress in patients with androgenetic alopecia, potentially offering advantages over global photography.

In this case series, researchers reported an unexpectedly rapid and positive response to a topical, hydrogel-based botanical treatment for androgenetic alopecia in both male and female volunteers, achieving significant improvement in hair loss within 90 days instead of the planned 270 days.

This study developed new graded visual scales integrating macroscopic and trichoscopic images for assessing the severity of androgenetic alopecia in men and women, potentially aiding in more objective disease evaluation.

This review found that recent innovations, such as topical medications, lasers, and microneedling, have shown significant reductions in androgenetic alopecia indicators, but more research is needed to refine treatments.

This abstract provides no specific research findings; it appears to contain journal subscription information and other non-research content.

This study demonstrates a significant correlation between anxiety, depression, and reduced quality of life in individuals with androgenetic alopecia.

This study found that dermoscopy is an effective tool for diagnosing and monitoring androgenetic alopecia in women, as it helped identify common signs such as hair miniaturization and peripilar brown halo.

This study identified specific gut bacterial pathways that may serve as potential therapeutic targets for managing androgenetic alopecia in obese individuals.

This survey reported that 37.6% of male AGA patients were satisfied with their treatments, with the highest satisfaction for 5-alpha-reductase inhibitors, and revealed differing perceptions between physicians and patients about AGA's impact on confidence and treatment involvement.

People often underestimate hair loss severity, with fewer seeking treatment, and it's more distressing for women.

This study found that a single injection of autologous cell micrografts significantly improved hair condition in women with androgenetic alopecia six months post-treatment.

This review discusses the characteristics, causes, diagnosis, and treatment options for androgenetic alopecia and emphasizes the importance of managing expectations due to the variability in therapeutic outcomes.

This study found that a new FAW-FS algorithm improved recognition of depression in patients with androgenic alopecia, and comprehensive psychological interventions positively impacted their rehabilitation outcomes.